Subtopic Deep Dive
p53 Tumor Suppressor Network
Research Guide
What is p53 Tumor Suppressor Network?
The p53 tumor suppressor network comprises the protein p53's interactome and signaling pathways that detect cellular stress and trigger responses including cell cycle arrest, DNA repair, and apoptosis to prevent tumorigenesis.
p53 acts as a transcription factor activated by DNA damage, oncogenic stress, and other signals. It regulates genes like CDK inhibitors and apoptosis effectors. Over 20 key papers from 1994-2002, led by Levine (7663 citations) and Sherr & Roberts (6054 citations), map its core network components.
Why It Matters
Network analysis of p53 pathways identifies therapeutic targets in cancers with p53 mutations, which occur in over 50% of tumors. Levine (1997) established p53 as the cellular gatekeeper, guiding drug development against pathway vulnerabilities. Sherr and Roberts (1999) detailed CDK regulation by p53-induced inhibitors, enabling G1 arrest therapies. Frisch and Francis (1994) linked p53 to anoikis via matrix interactions, informing metastasis treatments.
Key Research Challenges
Dynamic Network Modeling
Capturing p53's context-dependent interactions under varying stresses remains difficult due to feedback loops and post-translational modifications. Abraham (2001) highlights ATM/ATR kinase roles in checkpoint signaling integrated with p53. Systems biology models struggle with kinetic parameters from sparse data.
Therapeutic Resistance Mapping
p53-deficient cancers evade network suppression, complicating synthetic lethality strategies. Sherr and Roberts (1995) describe G1 CDK inhibitors downstream of p53 that tumors bypass. Identifying parallel pathways requires multi-omics integration.
Interactome Completeness
The full p53 interactome, including E2F and cyclin D1 regulators, lacks comprehensive mapping. Dyson (1998) details pRB-family control of E2F linked to p53. High-throughput screens miss transient or tissue-specific bindings.
Essential Papers
p53, the Cellular Gatekeeper for Growth and Division
Arnold J. Levine · 1997 · Cell · 7.7K citations
CDK inhibitors: positive and negative regulators of G1-phase progression
Charles J. Sherr, Joanna Roberts · 1999 · Genes & Development · 6.1K citations
Mitogen-dependent progression through the first gap phase (G1) and initiation of DNA synthesis (S phase) during the mammalian cell division cycle are cooperatively regulated by several classes of c...
Papillomaviruses and cancer: from basic studies to clinical application
Harald zur Hausen · 2002 · Nature reviews. Cancer · 4.0K citations
Inhibitors of mammalian G1 cyclin-dependent kinases.
Charles J. Sherr, Joanna Roberts · 1995 · Genes & Development · 3.3K citations
C J Sherr and J M Roberts Howard Hughes Medical Institute, Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38104, USA.
Disruption of epithelial cell-matrix interactions induces apoptosis
SM Frisch, H. Francis · 1994 · The Journal of Cell Biology · 3.2K citations
Cell-matrix interactions have major effects upon phenotypic features such as gene regulation, cytoskeletal structure, differentiation, and aspects of cell growth control. Programmed cell death (apo...
p53: puzzle and paradigm.
L J Ko, Carol Prives · 1996 · Genes & Development · 2.3K citations
The regulation of E2F by pRB-family proteins
Nicholas J. Dyson · 1998 · Genes & Development · 2.3K citations
Reading Guide
Foundational Papers
Start with Levine (1997, 7663 citations) for p53 gatekeeper concept, then Sherr and Roberts (1999, 6054 citations) for G1 regulation, and Frisch and Francis (1994, 3232 citations) for apoptosis links to build core network understanding.
Recent Advances
Study Abraham (2001, 1956 citations) on ATM/ATR checkpoints; Diehl et al. (1998, 2104 citations) on cyclin D1; Dyson (1998, 2306 citations) on E2F-pRB for pathway extensions.
Core Methods
Core techniques: CDK inhibitor assays (Sherr and Roberts 1995), apoptosis induction via matrix disruption (Frisch 1994), kinase signaling (Abraham 2001), and proteolysis assays (Diehl 1998).
How PapersFlow Helps You Research p53 Tumor Suppressor Network
Discover & Search
Research Agent uses citationGraph on Levine (1997) to reveal 7663-citing papers mapping p53 pathways, then findSimilarPapers uncovers Sherr and Roberts (1999) on CDK inhibitors, and exaSearch queries 'p53 stress signaling interactome' for 250M+ OpenAlex papers.
Analyze & Verify
Analysis Agent applies readPaperContent to extract pathway diagrams from Ko and Prives (1996), verifies claims with CoVe against Abraham (2001) checkpoint data, and runs PythonAnalysis for GRADE-scored statistical modeling of p53 activation kinetics using NumPy/pandas on extracted datasets.
Synthesize & Write
Synthesis Agent detects gaps in p53-cyclin D1 regulation from Diehl et al. (1998), flags contradictions between Sherr papers, and generates exportMermaid diagrams of the network; Writing Agent uses latexEditText, latexSyncCitations for Levine/Sherr refs, and latexCompile for publication-ready pathway figures.
Use Cases
"Model p53-induced G1 arrest kinetics from Sherr papers using Python."
Research Agent → searchPapers 'Sherr p53 CDK' → Analysis Agent → readPaperContent + runPythonAnalysis (pandas simulation of cyclin D1 proteolysis from Diehl 1998 data) → matplotlib plot of arrest probabilities.
"Generate LaTeX review of p53 apoptosis network with citations."
Synthesis Agent → gap detection on Frisch (1994) anoikis → Writing Agent → latexEditText for pathway text + latexSyncCitations (Levine 1997, Ashkenazi 1999) + latexCompile → PDF with embedded network diagram.
"Find code for p53 interactome simulations linked to papers."
Research Agent → citationGraph on Levine (1997) → Code Discovery workflow: paperExtractUrls → paperFindGithubRepo → githubRepoInspect → runnable Python script for network dynamics.
Automated Workflows
Deep Research workflow scans 50+ p53 papers via searchPapers, structures reports with GRADE evidence on Levine/Sherr networks, and flags therapeutic gaps. DeepScan applies 7-step CoVe to verify p53-ATM integration from Abraham (2001). Theorizer generates hypotheses on synthetic lethals by synthesizing Dyson (1998) E2F data with Frisch (1994) apoptosis.
Frequently Asked Questions
What defines the p53 tumor suppressor network?
p53's network includes stress sensors (ATM/ATR), transcription targets (CDK inhibitors, apoptosis genes), and feedback loops preventing cancer (Levine 1997; Ko and Prives 1996).
What are key methods in p53 network studies?
Studies use yeast-two-hybrid for interactomes, kinase assays for ATM/p53 signaling (Abraham 2001), and cyclin proteolysis assays (Diehl et al. 1998); recent work integrates ChIP-seq with dynamical modeling.
What are the most cited p53 papers?
Levine (1997, 7663 citations) on gatekeeper role; Sherr and Roberts (1999, 6054 citations) on CDK inhibitors; Ko and Prives (1996, 2347 citations) on p53 paradigms.
What open problems exist in p53 networks?
Unresolved: tissue-specific p53 interactomes, resistance bypass mechanisms in mutants (Sherr and Roberts 1995), and multi-stress integration models beyond ATM/ATR (Abraham 2001).
Research Cancer-related Molecular Pathways with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching p53 Tumor Suppressor Network with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Cancer-related Molecular Pathways Research Guide